Applied Therapeutics (APLT) Competitors

Gossamer Bio (NASDAQ:GOSS) and Applied Therapeutics (NASDAQ:APLT) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, media sentiment, analyst recommendations, institutional ownership, community ranking, earnings and dividends.

Which has more volatility and risk, GOSS or APLT?

Gossamer Bio has a beta of 1.81, indicating that its stock price is 81% more volatile than the S&P 500. Comparatively, Applied Therapeutics has a beta of 1.88, indicating that its stock price is 88% more volatile than the S&P 500.

Is GOSS or APLT more profitable?

Gossamer Bio's return on equity of -127.28% beat Applied Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Gossamer Bio	N/A	-127.28%	-22.12%
Applied Therapeutics	N/A	-260.75%	-76.04%

Do institutionals and insiders hold more shares of GOSS or APLT?

81.2% of Gossamer Bio shares are owned by institutional investors. Comparatively, 98.3% of Applied Therapeutics shares are owned by institutional investors. 5.0% of Gossamer Bio shares are owned by insiders. Comparatively, 8.6% of Applied Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Which has preferable valuation & earnings, GOSS or APLT?

Applied Therapeutics has lower revenue, but higher earnings than Gossamer Bio. Gossamer Bio is trading at a lower price-to-earnings ratio than Applied Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Gossamer Bio	$105.32M	3.01	-$179.82M	-$0.32	-4.38
Applied Therapeutics	$9.99M	6.17	-$119.76M	-$1.61	-0.33

Does the MarketBeat Community believe in GOSS or APLT?

Gossamer Bio received 72 more outperform votes than Applied Therapeutics when rated by MarketBeat users. Likewise, 66.38% of users gave Gossamer Bio an outperform vote while only 57.55% of users gave Applied Therapeutics an outperform vote.

Company	Underperform	Outperform
Gossamer Bio	Outperform Votes 152 66.38%	Underperform Votes 77 33.62%
Applied Therapeutics	Outperform Votes 80 57.55%	Underperform Votes 59 42.45%

Do analysts recommend GOSS or APLT?

Gossamer Bio presently has a consensus target price of $9.20, suggesting a potential upside of 557.14%. Applied Therapeutics has a consensus target price of $6.10, suggesting a potential upside of 1,050.94%. Given Applied Therapeutics' higher probable upside, analysts plainly believe Applied Therapeutics is more favorable than Gossamer Bio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Gossamer Bio	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Applied Therapeutics	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Does the media refer more to GOSS or APLT?

In the previous week, Applied Therapeutics had 16 more articles in the media than Gossamer Bio. MarketBeat recorded 17 mentions for Applied Therapeutics and 1 mentions for Gossamer Bio. Applied Therapeutics' average media sentiment score of 0.15 beat Gossamer Bio's score of 0.00 indicating that Applied Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Gossamer Bio	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Applied Therapeutics	4 Very Positive mention(s)	2 Positive mention(s)	11 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Applied Therapeutics beats Gossamer Bio on 9 of the 17 factors compared between the two stocks.